查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1467804

2024-2032 年按药物类别（促性腺激素、芳香酶抑制剂、选择性雌激素受体调节剂、双胍类等）、给药途径、配销通路、最终用户和地区分類的不孕不育药物市场报告

Infertility Drugs Market Report by Drug Class (Gonadotropin, Aromatase Inhibitors, Selective Estrogen Receptor Modulators, Biguanides, and Others), Route of Administration, Distribution Channel, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球不孕症药物市场规模达39亿美元。

不孕症药物是指用于治疗不孕症和增强个体生殖健康的各种药物。它们可以注射或口服。一些常用的不孕药物包括促性腺激素、芳香酶抑制剂、选择性雌激素受体调节剂（SERM）、双胍类、排卵兴奋剂、多巴胺激动剂和三环类抗忧郁剂。它们的作用是刺激女性卵巢的排卵和卵泡发育，而它们则有助于恢復男性睪固酮水平并提高精子品质以实现怀孕。近年来，不孕症药物在无法怀孕的夫妇中越来越受欢迎。

不孕不孕药物市场趋势：

不孕症药物透过恢復个人受孕的能力来帮助提高夫妇怀孕的机会。因此，不孕症和流产发生率的上升是推动市场成长的主要因素。除此之外，各国政府为提高人们对现有治疗方案的认识而采取的几项有利措施正在刺激对不孕症药物的需求。此外，由于忙碌的工作日程、随之而来的压力和生活方式的改变，癌症、肥胖、糖尿病、甲状腺、多囊性卵巢症候群（PCOS）和更年期疾病等慢性疾病的盛行率显着增加。同时，由于延迟怀孕、晚婚以及过度饮酒、吸毒和吸烟等不健康习惯导致的生育率下降，正在加速产品的采用率。此外，一些主要参与者正在从事研发（R＆D）活动，以推出具有更高功效、更低剂量要求和更少副作用的创新不孕症药物。此外，用于开发这些药物的公共资金的增加以及各个监管机构更快的药物批准正在推动市场的成长。其他因素，包括对仿製药的需求不断增加、医疗保健基础设施改善、消费者支出能力不断提高、快速城市化和技术进步，也为市场成长提供了积极的推动力。

本报告回答的关键问题：

  • 迄今为止，全球不孕症药物市场表现如何，未来几年将如何表现？
  • COVID-19 对全球不孕症药物市场有何影响？
  • 主要区域市场有哪些？
  • 根据药物类别分類的市场是怎么样的？
  • 根据给药途径，市场的分化为何？
  • 基于配销通路的市场区隔是什么？
  • 基于最终用户的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球不孕症药物市场的结构如何？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球不孕症药物市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依药物类别

  • 促性腺激素
    • 市场走向
    • 市场预测
  • 芳香酶抑制剂
    • 市场走向
    • 市场预测
  • 选择性雌激素受体调节剂 (SERM)
    • 市场走向
    • 市场预测
  • 双胍类
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依管理途径

  • 口服
    • 市场走向
    • 市场预测
  • 静脉
    • 市场走向
    • 市场预测
  • 皮下
    • 市场走向
    • 市场预测
  • 肌肉注射
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 医院药房
    • 市场走向
    • 市场预测
  • 零售药局
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 男性
    • 市场走向
    • 市场预测
  • 女性
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Bayer AG
    • Ferring Pharmaceuticals
    • Livzon Pharmaceutical Group Inc.
    • Mankind Pharma
    • Merck & Co. Inc.
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Theramex
Product Code: SR112024A5239

The global infertility drugs market size reached US$ 3.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.7% during 2024-2032.

Infertility drugs refer to various medications used to treat infertility and enhance the reproductive health of an individual. They are either injected or taken orally. Some commonly used infertility drugs include gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), biguanides, ovulatory stimulants, dopamine agonists, and tricyclic antidepressants. They work by stimulating ovulation and follicle development of the ovary in women, whereas they help restore testosterone levels and improve the quality of sperm in men to bring about pregnancy. In recent years, infertility drugs have gained traction among couples who are unable to conceive.

Infertility Drugs Market Trends:

Infertility drugs assist in enhancing the chances of pregnancy in couples by restoring the ability of an individual to contribute to conception. As a result, the rising incidences of infertility and miscarriage represents the primary factor driving the market growth. Besides this, several favorable initiatives undertaken by governments of various countries to spread awareness regarding the available treatment options are catalyzing the demand for infertility drugs. Additionally, there has been a significant increase in the prevalence of chronic diseases, such as cancer, obesity, diabetes, thyroid, polycystic ovarian syndrome (PCOS), and menopausal disorders, on account of hectic work schedules, accompanying stress, and lifestyle changes. Along with this, the declining fertility rates due to delayed pregnancies, late marriages, and unhealthy habits, such as excessive consumption of alcohol, drugs, and smoking, are accelerating the product adoption rates. Furthermore, several key players are engaging in research and development (R&D) activities to launch innovative infertility drugs with enhanced efficacy, lower dosage requirements, and fewer side effects. Moreover, the increasing public funding for developing these drugs and faster drug approvals from various regulatory bodies are propelling the market growth. Other factors, including the escalating demand for generic medicines, improving healthcare infrastructure, rising consumer expenditure capacities, rapid urbanization, and technological advancements, are also providing a positive thrust to the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global infertility drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug class, route of administration, distribution channel and end user.

Breakup by Drug Class:

Gonadotropin

Aromatase Inhibitors

Selective Estrogen Receptor Modulators (SERMs)

Biguanides

Others

Breakup by Route of Administration:

Oral

Intravenous

Subcutaneous

Intramuscular

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Others

Breakup by End User:

Male

Female

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.

Key Questions Answered in This Report:

  • How has the global infertility drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global infertility drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global infertility drugs market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Infertility Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Gonadotropin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Aromatase Inhibitors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Selective Estrogen Receptor Modulators (SERMs)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Biguanides
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intravenous
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Subcutaneous
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Intramuscular
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Male
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Female
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Ferring Pharmaceuticals
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Livzon Pharmaceutical Group Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Mankind Pharma
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Merck & Co. Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Merck KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Novartis AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Sanofi S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Theramex
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Infertility Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Infertility Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Infertility Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Infertility Drugs Market: Breakup by Drug Class (in %), 2023
  • Figure 5: Global: Infertility Drugs Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Infertility Drugs Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Infertility Drugs Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Infertility Drugs Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Infertility Drugs (Gonadotropin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Infertility Drugs (Gonadotropin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Infertility Drugs (Aromatase Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Infertility Drugs (Aromatase Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Infertility Drugs (Biguanides) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Infertility Drugs (Biguanides) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Infertility Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Infertility Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Infertility Drugs (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Infertility Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Infertility Drugs (Intravenous) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Infertility Drugs (Intravenous) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Infertility Drugs (Subcutaneous) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Infertility Drugs (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Infertility Drugs (Intramuscular) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Infertility Drugs (Intramuscular) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Infertility Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Infertility Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Infertility Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Infertility Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Infertility Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Infertility Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Infertility Drugs (Male) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Infertility Drugs (Male) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Infertility Drugs (Female) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Infertility Drugs (Female) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Infertility Drugs Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Infertility Drugs Industry: SWOT Analysis
  • Figure 87: Global: Infertility Drugs Industry: Value Chain Analysis
  • Figure 88: Global: Infertility Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Infertility Drugs Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Infertility Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 3: Global: Infertility Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 4: Global: Infertility Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Infertility Drugs Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Infertility Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Infertility Drugs Market: Competitive Structure
  • Table 8: Global: Infertility Drugs Market: Key Players